Management of bacterial and fungal infections in end stage liver disease and liver transplantation: Current options and future directions

doi:10.3748/wjg.v24.i38.4311

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 24, Issue 38

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (16776)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-2) series, Tables (1-4) series.

Item

Count

PDF

1503

HTML

11311

Figures (1-2)

288

Tables (1-4)

313

Sum=13415

Featured Article

The chart showing Browse series, Download series.

Item

Count

Browse

673

Download

571

Sum=1244

Publishing Process of This Article

Item

Count

Browse

962

Download

1155

Sum=2117

Oct 14, 2018 (publication date) through Dec 25, 2024

Times Cited of This Article

Times Cited (43)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Review

World J Gastroenterol. Oct 14, 2018; 24(38): 4311-4329
Published online Oct 14, 2018. doi: 10.3748/wjg.v24.i38.4311

Open in New Tab Full Size Figure Download Figure

Figure 1 Factors leading to increased susceptibility to infections in patients with liver cirrhosis.

Open in New Tab Full Size Figure Download Figure

Figure 2 Studies reporting the percentage of infections caused by methicillin-resistant Staphylococcus aureus, MDR Pseudomonas aeruginosa, and extended-spectrum beta-lactamase-producing Enterobacteriaceae following liver transplantation[79,91-93,95-97]. ¹Data reported for all solid organ transplants; ²MRSA data obtained from reference 98[98]. MRSA: Methicillin-resistant Staphylococcus aureus; MDR-PA: Multidrug-resistant Pseudomonas aeruginosa; ESBL-EB: Extended-spectrum-beta-lactamase Enterobacteriaceae.

Citation: Righi E. Management of bacterial and fungal infections in end stage liver disease and liver transplantation: Current options and future directions. World J Gastroenterol 2018; 24(38): 4311-4329
URL: https://www.wjgnet.com/1007-9327/full/v24/i38/4311.htm
DOI: https://dx.doi.org/10.3748/wjg.v24.i38.4311